Thank you for your email. These are relevant and very good questions.


PR about the LD Micro Conference... and Urano's response to an email...

"SAN FRANCISCO and GENEVA, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (AMBS), a diversified biotechnology company focused on the development of diagnostic and therapeutic products in the areas of neurology, psychiatry, ophthalmology and regenerative medicine"

"1. Your understanding is correct.

2. In Wolfram, this may delay the progression of the disease. In Type 1 diabetes patients, this may prevent the further destruction of insulin-producing cells.

3. Dantrolene does not provide a cure. This should be combined with a regenerative therapy.

Please feel free to contact me if you have any questions.

Kindly,

Fumi"

P.S. That is the first time I have seen the company use the term "therapeutic products in the area of regenerative therapy." Hello Mr. MANF, Mrs. MANF, and Family MANF!

Manolo